Alzheimer disease

References

• Qiang L, Yu W, Andreadis A, Luo M, Baas PW. Tau protects microtubules in the axon from severing by katanin. J Neurosci 2006; 26:3120 - 9; http://dx.doi.org/10.1523/JNEUROSCI.5392-05.2006; PMID: 16554463
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 2001; 81:741 - 66; PMID: 11274343
   PubMed Web of Science ®Google Scholar
• Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992; 256:184 - 5; http://dx.doi.org/10.1126/science.1566067; PMID: 1566067
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. The molecular pathology of Alzheimer’s disease. Neuron 1991; 6:487 - 98; http://dx.doi.org/10.1016/0896-6273(91)90052-2; PMID: 1673054
   PubMed Web of Science ®Google Scholar
• King ME, Kan H-M, Baas PW, Erisir A, Glabe CG, Bloom GS. Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid. J Cell Biol 2006; 175:541 - 6; http://dx.doi.org/10.1083/jcb.200605187; PMID: 17101697
   PubMed Web of Science ®Google Scholar
• Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol 1999; 155:853 - 62; http://dx.doi.org/10.1016/S0002-9440(10)65184-X; PMID: 10487842
   PubMed Web of Science ®Google Scholar
• McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 1999; 46:860 - 6; http://dx.doi.org/10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; PMID: 10589538
   PubMed Web of Science ®Google Scholar
• Nath S, Agholme L, Kurudenkandy FR, Granseth B, Marcusson J, Hallbeck M. Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β-amyloid. J Neurosci 2012; 32:8767 - 77; http://dx.doi.org/10.1523/JNEUROSCI.0615-12.2012; PMID: 22745479
   PubMed Web of Science ®Google Scholar
• Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature 2012; 485:651 - 5; http://dx.doi.org/10.1038/nature11060; PMID: 22660329
   PubMed Web of Science ®Google Scholar
• Picone P, Carrotta R, Montana G, Nobile MR, San Biagio PL, Di Carlo M. Abeta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures. Biophys J 2009; 96:4200 - 11; http://dx.doi.org/10.1016/j.bpj.2008.11.056; PMID: 19450490
   PubMed Web of Science ®Google Scholar
• Seward M, Swanson E, Roberson ED, Bloom GS. Amyloid-β signals through tau to drive neuronal cell cycle re-entry in Alzheimer’s disease. 2012;
   Google Scholar
• Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer’s disease. J Neurosci 2002; 22:1858 - 67; PMID: 11880515
   PubMed Web of Science ®Google Scholar
• Weingarten MD, Lockwood AH, Hwo S-Y, Kirschner MW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 1975; 72:1858 - 62; http://dx.doi.org/10.1073/pnas.72.5.1858; PMID: 1057175
   PubMed Web of Science ®Google Scholar
• Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986; 83:4913 - 7; http://dx.doi.org/10.1073/pnas.83.13.4913; PMID: 3088567
   PubMed Web of Science ®Google Scholar
• Kondo J, Honda T, Mori H, Hamada Y, Miura R, Ogawara M, et al. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1988; 1:827 - 34; http://dx.doi.org/10.1016/0896-6273(88)90130-4; PMID: 2483105
   PubMed Web of Science ®Google Scholar
• Kosik KS, Orecchio LD, Binder L, Trojanowski JQ, Lee VM-Y, Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1988; 1:817 - 25; http://dx.doi.org/10.1016/0896-6273(88)90129-8; PMID: 2483104
   PubMed Web of Science ®Google Scholar
• Dixit R, Ross JL, Goldman YE, Holzbaur EL. Differential regulation of dynein and kinesin motor proteins by tau. Science 2008; 319:1086 - 9; http://dx.doi.org/10.1126/science.1152993; PMID: 18202255
   PubMed Web of Science ®Google Scholar
• Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer’s disease. J Cell Biol 1998; 143:777 - 94; http://dx.doi.org/10.1083/jcb.143.3.777; PMID: 9813097
   PubMed Web of Science ®Google Scholar
• Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 2002; 156:1051 - 63; http://dx.doi.org/10.1083/jcb.200108057; PMID: 11901170
   PubMed Web of Science ®Google Scholar
• Trinczek B, Ebneth A, Mandelkow EM, Mandelkow E. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J Cell Sci 1999; 112:2355 - 67; PMID: 10381391
   PubMed Web of Science ®Google Scholar
• Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001; 24:1121 - 59; http://dx.doi.org/10.1146/annurev.neuro.24.1.1121; PMID: 11520930
   PubMed Web of Science ®Google Scholar
• Hanger DP, Anderton BH, Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 2009; 15:112 - 9; http://dx.doi.org/10.1016/j.molmed.2009.01.003; PMID: 19246243
   PubMed Web of Science ®Google Scholar
• Porzig R, Singer D, Hoffmann R. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem Biophys Res Commun 2007; 358:644 - 9; http://dx.doi.org/10.1016/j.bbrc.2007.04.187; PMID: 17499212
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 44; http://dx.doi.org/10.1126/science.6801762; PMID: 6801762
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Some speculations about prions, amyloid, and Alzheimer’s disease. N Engl J Med 1984; 310:661 - 3; http://dx.doi.org/10.1056/NEJM198403083101021; PMID: 6363926
   PubMed Web of Science ®Google Scholar
• Frost B, Diamond MI. Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 2010; 11:155 - 9; PMID: 20029438
   PubMed Web of Science ®Google Scholar
• Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 2010; 33:317 - 25; http://dx.doi.org/10.1016/j.tins.2010.04.003; PMID: 20493564
   PubMed Web of Science ®Google Scholar
• Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 2011; 70:532 - 40; http://dx.doi.org/10.1002/ana.22615; PMID: 22028219
   PubMed Web of Science ®Google Scholar
• Kim J, Holtzman DM. Medicine. Prion-like behavior of amyloid-beta. Science 2010; 330:918 - 9; http://dx.doi.org/10.1126/science.1198314; PMID: 21071652
   PubMed Web of Science ®Google Scholar
• Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E. Cell-to-cell transmission of nonprion protein aggregates. Nature Rev Neurol 2010; 6:702 - 6; http://dx.doi.org/10.1038/nrneurol.2010.145
   PubMed Web of Science ®Google Scholar
• Novak P, Prcina M, Kontsekova E. Tauons and prions: infamous cousins?. J Alzheimers Dis 2011; 26:413 - 30; PMID: 21694453
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Cell biology. A unifying role for prions in neurodegenerative diseases. Science 2012; 336:1511 - 3; http://dx.doi.org/10.1126/science.1222951; PMID: 22723400
   PubMed Web of Science ®Google Scholar
• Harris JA, Devidze N, Verret L, Ho K, Halabisky B, Thwin MT, et al. Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 2010; 68:428 - 41; http://dx.doi.org/10.1016/j.neuron.2010.10.020; PMID: 21040845
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K. Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?. Acta Neuropathol 2011; 121:589 - 95; http://dx.doi.org/10.1007/s00401-011-0825-z; PMID: 21516512
   PubMed Web of Science ®Google Scholar
• Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009; 11:909 - 13; http://dx.doi.org/10.1038/ncb1901; PMID: 19503072
   PubMed Web of Science ®Google Scholar
• de Calignon A, Polydoro M, Suárez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, et al. Propagation of tau pathology in a model of early Alzheimer’s disease. Neuron 2012; 73:685 - 97; http://dx.doi.org/10.1016/j.neuron.2011.11.033; PMID: 22365544
   PubMed Web of Science ®Google Scholar
• Guo JL, Lee VM. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 2011; 286:15317 - 31; http://dx.doi.org/10.1074/jbc.M110.209296; PMID: 21372138
   PubMed Web of Science ®Google Scholar
• Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, et al. Trans-synaptic spread of tau pathology in vivo. PLoS One 2012; 7:e31302; http://dx.doi.org/10.1371/journal.pone.0031302; PMID: 22312444
   PubMed Web of Science ®Google Scholar
• Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ, et al. Abeta accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am J Pathol 2010; 177:1977 - 88; http://dx.doi.org/10.2353/ajpath.2010.100346; PMID: 20802182
   PubMed Web of Science ®Google Scholar
• Miller Y, Ma B, Nussinov R. Synergistic interactions between repeats in tau protein and Aβ amyloids may be responsible for accelerated aggregation via polymorphic states. Biochemistry 2011; 50:5172 - 81; http://dx.doi.org/10.1021/bi200400u; PMID: 21506544
   PubMed Web of Science ®Google Scholar
• Pauwels K, Williams TL, Morris KL, Jonckheere W, Vandersteen A, Kelly G, et al. Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease. J Biol Chem 2012; 287:5650 - 60; http://dx.doi.org/10.1074/jbc.M111.264473; PMID: 22157754
   PubMed Web of Science ®Google Scholar
• Stöhr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ, et al. Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions. Proc Natl Acad Sci U S A 2012; 109:11025 - 30; http://dx.doi.org/10.1073/pnas.1206555109; PMID: 22711819
   PubMed Web of Science ®Google Scholar
• Guo JP, Arai T, Miklossy J, McGeer PL. Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer’s disease. Proc Natl Acad Sci U S A 2006; 103:1953 - 8; http://dx.doi.org/10.1073/pnas.0509386103; PMID: 16446437
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, Jackson GR, Kayed R. Preparation and characterization of neurotoxic tau oligomers. Biochemistry 2010; 49:10039 - 41; http://dx.doi.org/10.1021/bi1016233; PMID: 21047142
   PubMed Web of Science ®Google Scholar
• Busciglio J, Lorenzo A, Yeh J, Yankner BA. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995; 14:879 - 88; http://dx.doi.org/10.1016/0896-6273(95)90232-5; PMID: 7718249
   PubMed Web of Science ®Google Scholar
• Götz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001; 293:1491 - 5; http://dx.doi.org/10.1126/science.1062097; PMID: 11520988
   PubMed Web of Science ®Google Scholar
• Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A 2011; 108:5819 - 24; http://dx.doi.org/10.1073/pnas.1017033108; PMID: 21421841
   PubMed Web of Science ®Google Scholar
• Lewis J, Dickson DW, Lin W-L, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001; 293:1487 - 91; http://dx.doi.org/10.1126/science.1058189; PMID: 11520987
   PubMed Web of Science ®Google Scholar
• Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A. Tau is essential to β -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 2002; 99:6364 - 9; http://dx.doi.org/10.1073/pnas.092136199; PMID: 11959919
   PubMed Web of Science ®Google Scholar
• Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model. Science 2007; 316:750 - 4; http://dx.doi.org/10.1126/science.1141736; PMID: 17478722
   PubMed Web of Science ®Google Scholar
• Seino Y, Kawarabayashi T, Wakasaya Y, Watanabe M, Takamura A, Yamamoto-Watanabe Y, et al. Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model. J Neurosci Res 2010; 88:3547 - 54; http://dx.doi.org/10.1002/jnr.22516; PMID: 20936700
   PubMed Web of Science ®Google Scholar
• Zempel H, Thies E, Mandelkow E, Mandelkow EM. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci 2010; 30:11938 - 50; http://dx.doi.org/10.1523/JNEUROSCI.2357-10.2010; PMID: 20826658
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82:239 - 59; http://dx.doi.org/10.1007/BF00308809; PMID: 1759558
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K. The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol 2011; 121:171 - 81; http://dx.doi.org/10.1007/s00401-010-0789-4; PMID: 21170538
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18:351 - 7; http://dx.doi.org/10.1016/S0197-4580(97)00056-0; PMID: 9330961
   PubMed Web of Science ®Google Scholar
• Schönheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 2004; 25:697 - 711; http://dx.doi.org/10.1016/j.neurobiolaging.2003.09.009; PMID: 15165691
   PubMed Web of Science ®Google Scholar
• Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, et al. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 1998; 95:13103 - 7; http://dx.doi.org/10.1073/pnas.95.22.13103; PMID: 9789048
   PubMed Web of Science ®Google Scholar
• Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393:702 - 5; http://dx.doi.org/10.1038/31508; PMID: 9641683
   PubMed Web of Science ®Google Scholar
• Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 2010; 330:980 - 2; http://dx.doi.org/10.1126/science.1194516; PMID: 20966215
   PubMed Web of Science ®Google Scholar
• Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, et al. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci 2000; 20:3606 - 11; PMID: 10804202
   PubMed Web of Science ®Google Scholar
• Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006; 313:1781 - 4; http://dx.doi.org/10.1126/science.1131864; PMID: 16990547
   PubMed Web of Science ®Google Scholar
• Walker LC, Callahan MJ, Bian F, Durham RA, Roher AE, Lipinski WJ. Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides 2002; 23:1241 - 7; http://dx.doi.org/10.1016/S0196-9781(02)00059-1; PMID: 12128081
   PubMed Web of Science ®Google Scholar
• Kayed R, Canto I, Breydo L, Rasool S, Lukacsovich T, Wu J, et al. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers. Mol Neurodegener 2010; 5:57; http://dx.doi.org/10.1186/1750-1326-5-57; PMID: 21144050
   PubMed Web of Science ®Google Scholar
• Davis RC, Marsden IT, Maloney MT, Minamide LS, Podlisny M, Selkoe DJ, et al. Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation. Mol Neurodegener 2011; 6:10; http://dx.doi.org/10.1186/1750-1326-6-10; PMID: 21261978
   PubMed Web of Science ®Google Scholar
• Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007; 27:2866 - 75; http://dx.doi.org/10.1523/JNEUROSCI.4970-06.2007; PMID: 17360908
   PubMed Web of Science ®Google Scholar
• Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 2008; 14:837 - 42; http://dx.doi.org/10.1038/nm1782; PMID: 18568035
   PubMed Web of Science ®Google Scholar
• Portelius E, Westman-Brinkmalm A, Zetterberg H, Blennow K. Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry. J Proteome Res 2006; 5:1010 - 6; http://dx.doi.org/10.1021/pr050475v; PMID: 16602710
   PubMed Web of Science ®Google Scholar
• Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, Kehlen A, et al. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology. Nat Med 2008; 14:1106 - 11; http://dx.doi.org/10.1038/nm.1872; PMID: 18836460
   PubMed Web of Science ®Google Scholar
• Jeganathan S, von Bergen M, Mandelkow E-M, Mandelkow E. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments. Biochemistry 2008; 47:10526 - 39; http://dx.doi.org/10.1021/bi800783d; PMID: 18783251
   PubMed Web of Science ®Google Scholar
• Wilson DM, Binder LI. Free fatty acids stimulate the polymerization of tau and amyloid β peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer’s disease. Am J Pathol 1997; 150:2181 - 95; PMID: 9176408
   PubMed Web of Science ®Google Scholar
• Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 1996; 383:550 - 3; http://dx.doi.org/10.1038/383550a0; PMID: 8849730
   PubMed Web of Science ®Google Scholar
• Kampers T, Friedhoff P, Biernat J, Mandelkow EM, Mandelkow E. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett 1996; 399:344 - 9; http://dx.doi.org/10.1016/S0014-5793(96)01386-5; PMID: 8985176
   PubMed Web of Science ®Google Scholar
• Patterson KR, Remmers C, Fu Y, Brooker S, Kanaan NM, Vana L, et al. Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease. J Biol Chem 2011; 286:23063 - 76; http://dx.doi.org/10.1074/jbc.M111.237974; PMID: 21550980
   PubMed Web of Science ®Google Scholar
• Friedhoff P, von Bergen M, Mandelkow EM, Davies P, Mandelkow E. A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc Natl Acad Sci U S A 1998; 95:15712 - 7; http://dx.doi.org/10.1073/pnas.95.26.15712; PMID: 9861035
   PubMed Web of Science ®Google Scholar
• Frost B, Jacks RL, Diamond MI. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 2009; 284:12845 - 52; http://dx.doi.org/10.1074/jbc.M808759200; PMID: 19282288
   PubMed Web of Science ®Google Scholar
• Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M. Seeded aggregation and toxicity of alpha-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem 2010; 285:34885 - 98; http://dx.doi.org/10.1074/jbc.M110.148460; PMID: 20805224
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR, et al. Identification of oligomers at early stages of tau aggregation in Alzheimer’s disease. FASEB J 2012; 26:1946 - 59; http://dx.doi.org/10.1096/fj.11-199851; PMID: 22253473
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener 2011; 6:39; http://dx.doi.org/10.1186/1750-1326-6-39; PMID: 21645391
   PubMed Web of Science ®Google Scholar
• Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell 2010; 142:387 - 97; http://dx.doi.org/10.1016/j.cell.2010.06.036; PMID: 20655099
   PubMed Web of Science ®Google Scholar
• Vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S, et al. Tau reduction prevents Abeta-induced defects in axonal transport. Science 2010; 330:198; http://dx.doi.org/10.1126/science.1194653; PMID: 20829454
   PubMed Web of Science ®Google Scholar